CN Patent
CN103417498B — 一种替加环素冻干粉针剂的制备方法
Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2017-09-12 · 9y expired
What this patent protects
本申请提供了一种替加环素冻干粉针剂的制备方法。该方法克服了替加环素不稳定、易氧化变质的缺点,提供一种质量稳定、总降解产物控制在0.2%以内,且无污染、便于操作、储存和运输的注射用替加环素冻干粉针注射剂。
USPTO Abstract
本申请提供了一种替加环素冻干粉针剂的制备方法。该方法克服了替加环素不稳定、易氧化变质的缺点,提供一种质量稳定、总降解产物控制在0.2%以内,且无污染、便于操作、储存和运输的注射用替加环素冻干粉针注射剂。
Drugs covered by this patent
- Tygacil (TIGECYCLINE) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.